Kufstein, Austria

Gerhard Fleissner

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Fleissner. Retrieved from https://idiyas.com/inventor/gerhard-fleissner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerhard Fleissner: Innovator in Macrolides

Introduction

Gerhard Fleissner is a notable inventor based in Kufstein, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides. His work has been recognized through the granting of a patent, showcasing his innovative approach to drug development.

Latest Patents

Gerhard Fleissner holds 1 patent related to macrolides. This patent reflects his expertise and dedication to advancing medical science through innovative solutions.

Career Highlights

Fleissner is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking projects that aim to improve patient outcomes through effective medications.

Collaborations

Throughout his career, Fleissner has collaborated with esteemed colleagues, including Helmut Häcker and Ernst Küsters. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical research.

Conclusion

Gerhard Fleissner's contributions to the field of macrolides and his work with Novartis AG highlight his importance as an inventor in the pharmaceutical industry. His innovative spirit continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…